Browse the newest complete recall records currently stored from FDA enforcement reports and NHTSA vehicle campaigns. “Latest” refers to the newest source-dated record in this database, not the timestamp of our last API check.
The newest recall records with useful source details are listed here.
Defective Container: Product may leak when squeezed or when not in an upright position determined to be due to defects in the bottle neck finish and insufficient tightening.
CGMP Deviations: lots made with same active pharmaceutical ingredient (API) as lots that were rejected due to manufacturing issues that could cause the product to be out of specification…
Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.
Ford Motor Company (Ford) is recalling certain 2022 Bronco and Ranger vehicles. The windshield may not have been properly bonded to the vehicle, which could allow it to detach during a…
Nissan North America, Inc. (Nissan) is recalling certain 2020-2022 Frontier and Titan vehicles. The transmission parking pawl may not engage when the vehicle is shifted into park, which can…
Ford Motor Company (Ford) is recalling certain 2022 Lincoln Aviator and Ford Explorer vehicles. The engine rails may have been improperly heat-treated. As such, these vehicles fail to…
General Motors, LLC (GM) is recalling certain 2022 Cadillac XT5, XT6, and GMC Acadia All-Wheel Drive (AWD) vehicles. The fuel tank rollover valve may not provide a proper seal in the event…
cGMP deviations
Lack of assurance of sterility
CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.
Subpotent Drug: FDA analysis has revealed some bottles of these products were sub potent for ethanol.
Marketed Without An Unapproved NDA/ANDA: Product lot found to be tainted with undeclared diclofenac, an FDA approved nonsteroidal anti-inflammatory drug (NSAID) for the treatment of pain…
Lack of assurance of sterility
CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.
Lack of assurance of sterility
Failed Dissolution Specifications: Out of specification test results observed in dissolution testing during long term stability study.
Lack of assurance of sterility
Lack of assurance of sterility
Marketed Without An Unapproved NDA/ANDA: All lots were found to be unapproved drugs based on labeling claims.
Marketed Without An Unapproved NDA/ANDA: All lots were found to be unapproved drugs based on labeling claims.
General Motors, LLC (GM) is recalling certain 2022 Cadillac XT5, XT6, and GMC Acadia vehicles. The left-rear suspension toe link may have been tightened improperly, which could result in a…
Failed Impurities/Degradation Specifications.
Failed Impurities/Degradation Specifications.
cGMP deviations: Temperature abuse
Browse recent months with enough recall history for useful comparison.
